| Literature DB >> 27320081 |
Erna Li1,2, Xiao Wei2, Yanyan Ma3,2, Zhe Yin4, Huan Li2, Weishi Lin2, Xuesong Wang2, Chao Li5, Zhiqiang Shen5, Ruixiang Zhao3, Huiying Yang4, Aimin Jiang1, Wenhui Yang4, Jing Yuan2, Xiangna Zhao2.
Abstract
Enterobacter aerogenes (Enterobacteriaceae) is an important opportunistic pathogen that causes hospital-acquired pneumonia, bacteremia, and urinary tract infections. Recently, multidrug-resistant E. aerogenes have been a public health problem. To develop an effective antimicrobial agent, bacteriophage phiEap-2 was isolated from sewage and its genome was sequenced because of its ability to lyse the multidrug-resistant clinical E. aerogenes strain 3-SP. Morphological observations suggested that the phage belongs to the Siphoviridae family. Comparative genome analysis revealed that phage phiEap-2 is related to the Salmonella phage FSL SP-031 (KC139518). All of the structural gene products (except capsid protein) encoded by phiEap-2 had orthologous gene products in FSL SP-031 and Serratia phage Eta (KC460990). Here, we report the complete genome sequence of phiEap-2 and major findings from the genomic analysis. Knowledge of this phage might be helpful for developing therapeutic strategies against E. aerogenes.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27320081 PMCID: PMC4913238 DOI: 10.1038/srep28338
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Isolated enterobacteria phage phiEap-2.
(a) Plaques of phage phiEap-2 on E. aerogenes 3-SP. (b) Transmission electron micrograph (TEM) of phage phiEap-2 at × 150 000. The bar indicates 100 nm. (c) One-step growth curve of phiEap-2. Phages were grown in an exponential phase culture of E. aerogenes. (d) Stability of phage phiEap-2 at different temperatures. (e) Stability of phage phiEap-2 at different pH.
Host range infection of the phage phiEap-2 and efficiency of plating.
| Species | ID | Infection | Efficiency of plating (EOP) |
|---|---|---|---|
| 3-SP | + | 1.00 | |
| 201316724 | + | 1.12 | |
| 2015-301 | + | 0.84 | |
| 13208 | − | 0 | |
| A29864 | − | 0 | |
| A36179 | − | 0 | |
| AH10 | − | 0 | |
| AH12 | + | 0.97 | |
| AH13 | + | 0.85 | |
| AH14 | + | 0.60 | |
| AH15 | + | 0.20 | |
| AH17 | + | 0.51 | |
| AH18 | + | 1.03 | |
| AH2 | − | 0 | |
| AH20 | + | 0.18 | |
| AH21 | + | 1.01 | |
| AH22 | + | 0.59 | |
| AH24 | − | 0 | |
| AH25 | + | 0.03 | |
| AH28 | + | 1.12 | |
| AH29 | + | 0.63 | |
| AH3 | + | 0.23 | |
| AH30 | + | 0.29 | |
| AH32 | + | 0.80 | |
| AH33 | − | 0 | |
| AH34 | + | 0.61 | |
| AH36 | + | 0.75 | |
| T5282 | − | 0 | |
| TI3 | − | 0 | |
| 45401 | − | 0 | |
| 45402 | − | 0 | |
| wk2050 | − | 0 | |
| 201315732 | − | 0 | |
| wj-1 | − | 0 | |
| wj-2 | − | 0 | |
| wj-3 | − | 0 | |
| ATCC 25922 | − | 0 | |
| ATCC BAA-1706 | − | 0 | |
| A22732 | − | 0 | |
| P10164 | − | 0 | |
| YNKP001 | − | 0 | |
| 9665 | − | 0 | |
| P10159 | − | 0 | |
| J5421 | − | 0 | |
| PA01 | − | 0 | |
| N1 | − | 0 | |
| #1083 | − | 0 |
−absent; +present.
Figure 2Restriction fragment length polymorphism analysis of phiEap-2 DNA.
Genomic DNA from phage phiEap-2 was digested with the enzymes indicated (AhdI and SacI) and run on an agarose gel (0.7%). The length of fragments generated by digestion of the linear genome or the circular genome was showed on the right side of the electrophoresis map.
Figure 3Phylogenetic tree based on large terminase subunits of selected bacteriophages.
The large terminase subunits were compared using the ClustalW program, and the phylogenetic tree was generated using the neighbour-joining method and 1000 bootstrap replicates. FSL SP-031, GenBank accession no. NC_021775; phiEap-2, GenBank accession no. KT287080; Eta, GenBank accession no. KC460990; FSL SP-101, GenBank accession no. KC139511; K1-dep(1), GenBank accession no. GU196278; SS3e, GenBank accession no. NC_006940; T1, GenBank accession no. AY216660.
Phage phiEap-2 gene annotations.
| ORFs | Strand | Nucleotide position | Length (aa) | Conserved Protein Domain Family | Best match (%) | Vs FSL SP-031 | Vs Eta | Function |
|---|---|---|---|---|---|---|---|---|
| ORF1 | + | 409–582 | 58 | |||||
| ORF2 | + | 582–983 | 133 | FSL SP-031 orf18 (54%) | orf18 (54%) | |||
| ORF3 | + | 976–1494 | 172 | pfam13392; pfam00847; PHA00280 | SETP7 orf42 (49%) | HNH endonuclease | ||
| ORF4 | + | 1491–1688 | 65 | FSL SP-031 orf19 (89%) | orf19 (89%) | |||
| ORF5 | + | 1770–2096 | 108 | pfam11753 | FSL SP-031 orf20 (82%) | orf20 (82%) | ||
| ORF6 | + | 2500–2781 | 93 | SETP7 orf57 (53%) | orf22 (53%) | |||
| ORF7 | + | 2783–3067 | 94 | SETP7 orf58 (57%) | orf23 (45%) | Class I holin | ||
| ORF8 | + | 3048–3533 | 161 | cd00737; COG3772; pfam00959 | FSL SP-031 orf24 (80%) | orf24 (80%) | Lysozyme | |
| ORF9 | + | 3772–3957 | 62 | |||||
| ORF10 | + | 3954–4097 | 47 | FSL SP-031 orf25 (93%) | orf25 (93%) | |||
| ORF11 | + | 4275–4445 | 56 | pfam10930 | FSL SP-031 orf26 (87%) | orf26 (87%) | ||
| ORF12 | + | 4585–4821 | 78 | FSL SP-031 orf27 (49%) | orf27 (49%) | |||
| ORF13 | + | 4818–4973 | 52 | FSL SP-031 orf28 (50%) | orf28 (50%) | |||
| ORF14 | + | 4960–5220 | 86 | pYD38-A orf74 (74%) | ||||
| ORF15 | + | 5223–5444 | 73 | pfam06322 | FSL SP-031 orf29 (72%) | orf29 (72%) | ||
| ORF16 | + | 5441–5608 | 56 | |||||
| ORF17 | + | 5738–6241 | 167 | FSL SP-031 orf31 (60%) | orf31 (60%) | |||
| ORF18 | + | 6216–7487 | 423 | TIGR01547; pfam03237 | FSL SP-031 orf32 (89%) | orf32 (89%) | orf40 (57%) | Terminase large subunit |
| ORF19 | + | 7500–8987 | 495 | pfam13264 | K1-dep(1) orf2 (80%) | orf33 (77%) | orf42 (65%) | Structural protein |
| ORF20 | − | 9014–9217 | 68 | |||||
| ORF21 | + | 9302–10345 | 347 | TIGR01641; pfam04233; COG2369 | FSL SP-031 orf34 (91%) | orf34 (91%) | orf43 (66%) | Head morphogenesis protein |
| ORF22 | + | 10345–10794 | 149 | pfam07679 | FSL SP-031 orf35 (67%) | orf35 (67%) | orf44 (55%) | Tail protein |
| ORF23 | + | 10794–11363 | 189 | FSL SP-031 orf35 (35%) | orf35 (35%) | orf44 (35%) | ||
| ORF24 | + | 11367–11501 | 44 | BA3 orf20 (66%) | ||||
| ORF25 | − | 11567–11779 | 71 | Acj61 p098 (39%) | ||||
| ORF26 | + | 12153–12542 | 129 | FSL SP-031 orf37 (61%) | orf37 (61%) | |||
| ORF27 | + | 12736–13386 | 216 | Eta orf50 (64%) | orf40 (54%) | orf50 (64%) | Scaffold protein | |
| ORF28 | + | 13393–14361 | 322 | K1-dep(1) orf8 (93%) | Major capsid protein | |||
| ORF29 | + | 14422–14607 | 61 | K1-dep(1) orf 9 (56%) | ||||
| ORF30 | + | 14611–15117 | 168 | PRK00007 | FSL SP-031 orf45 (75%) | orf45 (75%) | orf54 (70%) | Head-tail joining protein |
| ORF31 | + | 15120–15743 | 207 | FSL SP-031 orf46 (73%) | orf46 (73%) | orf55 (72%) | Neck protein | |
| ORF32 | + | 15740–16099 | 119 | FSL SP-031 orf47 (82%) | orf47 (82%) | orf56 (77%) | Tail protein | |
| ORF33 | + | 16096–16494 | 132 | pfam04883 | FSL SP-031 orf48 (58%) | orf48 (58%) | orf57 (51%) | Tail protein |
| ORF34 | + | 16494–16910 | 138 | pfam13554 | FSL SP-031 orf49 (90%) | orf49 (90%) | orf58 (81%) | Tail protein |
| ORF35 | + | 16913–18085 | 390 | FSL SP-031 orf50 (86%) | orf50 (86%) | orf59 (77%) | Tail protein | |
| ORF36 | − | 18108–18440 | 111 | FSL SP-031 orf51 (41%) | orf51 (41%) | |||
| ORF37 | + | 18602–19018 | 138 | FSL SP-031 orf52 (82%) | orf52 (82%) | orf61 (57%) | ||
| ORF38 | + | 19108–19380 | 90 | FSL SP-031 orf53 (81%) | orf53 (81%) | orf62 (53%) | ||
| ORF39 | + | 19373–21607 | 744 | pfam06791; PTZ00121 | FSL SP-031 orf54 (65%) | orf54 (65%) | orf63 (53%) | Tail tape measure protein |
| ORF40 | + | 21610–22104 | 164 | Eta orf64 (75%) | orf55 (64%) | orf64 (75%) | ||
| ORF41 | + | 22101–22613 | 170 | pfam08875 | Eta orf66 (78%) | orf56 (69%) | orf66 (78%) | |
| ORF42 | + | 22673–22975 | 100 | Eta orf67 (64%) | orf57 (58%) | orf67 (64%) | ||
| ORF43 | + | 23041–25557 | 838 | COG4733 | FSL SP-031 orf58 (60%) | orf58 (60%) | orf68 (60%) | Tail fiber protein |
| ORF44 | + | 25570–27558 | 662 | pfam12708; pfam13229; TIGR04247 | Eta orf69 (37%) | orf59 (24%) | orf69 (37%) | Tailspike protein |
| ORF45 | + | 27555–27707 | 50 | |||||
| ORF46 | − | 27736–27993 | 86 | pfam13600; cd14812 | FSL SP-101 orf1 (72%) | orf1 (68%) | ||
| ORF47 | − | 27996–29432 | 478 | cd00046; pfam00271; pfam00176; smart00487; COG0553 | FSL SP-031 orf2 (96%) | orf2 (96%) | Helicase | |
| ORF48 | − | 29429–29572 | 48 | |||||
| ORF49 | − | 29572–29745 | 58 | |||||
| ORF50 | − | 29736–30080 | 114 | PHA00527 | Marshall orf108 (47%) | |||
| ORF51 | − | 30077–30469 | 130 | pfam08774 | FSL SP-031 orf3 (65%) | orf3 (65%) | Restriction endonuclease | |
| ORF52 | − | 30552–31031 | 159 | pfam13392; pfam00847; PHA00280 | ||||
| ORF53 | − | 31021–33234 | 737 | cd08642; smart00482; pfam00476; pfam01612; PRK14975; TIGR00593; COG0749 | FSL SP-031 orf5 (74%) | orf5 (74%) | DNA polymerase I | |
| ORF54 | − | 33293–33973 | 226 | pfam10991 | FSL SP-031 orf7 (85%) | orf7 (85%) | ||
| ORF55 | − | 34058–35452 | 464 | pfam10926 | FSL SP-031 orf9 (72%) | orf9 (72%) | ||
| ORF56 | − | 35452–35688 | 78 | FSL SP-031 orf11 (58%) | orf11 (58%) | |||
| ORF57 | − | 35685–35906 | 74 | |||||
| ORF58 | − | 35955–36113 | 53 | |||||
| ORF59 | − | 36117–36608 | 163 | PRK13108; TIGR00457 | FSL SP-031 orf14 (42%) | orf14 (42%) | ||
| ORF60 | − | 36611–37099 | 162 | pfam13392; pfam00847; PHA00280 | SETP7 orf42 (67%) | HNH endonuclease | ||
| ORF61 | + | 37244–37465 | 73 | cd00093; pfam13443; smart00530; COG3655; PRK09706; COG1396 | FSL SP-031 orf15 (39%) | orf15 (39%) | ||
| ORF62 | + | 37594–39897 | 767 | pfam13481; cd01125 | FSL SP-031 orf16 (75%) | orf16 (75%) | Replicative helicase/primease |
aamino acids.
Figure 4Genomic structure of phiEap-2.
The genome map was performed using the CLC Main Workbench, version 6.1.1 (CLC bio, Aarhus, Denmark). Arrows represent predicted ORFs, the direction of the arrow represents the direction of transcription. Different colors denote different functional groups of bacteriophage genes.